ASH 2009: Novel agents for multiple myeloma
ASH 2009: Novel agents for multiple myeloma
Highlights in store at the 7th European Breast Cancer Conference, 24 - 27 March
The future of cancer policy in the UK
The experience of the Greater Manchester and Cheshire Cancer Network, and UK policy
Problem areas and concluding advice - Molecular Pathology Education Module 4
HER 2: Interpretation of ICH and FISH Assays - Molecular Pathology Education Module 3
Tips on HER2 Assays - Molecular Pathology Education Module 2
How to test for HER2, the lessons and pitfalls - Molecular Pathology Education Module 1
The UK's National Awareness and Early Diagnosis Initiative
Screening for breast cancer, how often?
IMPAKT 2009 and the future
Translational breast cancer research